KLF5 and triple-negative breast carcinoma: Furthermore, we utilised the triple negative breast cancer cell line, CAL-51, which does not express ARID1A, complemented these cells with vectors expressing GFP or GFP-ARID1A WT (Supplementary Fig. 1g) and assessed the effect of KLF5 inhibition on their growth.